


To provide a stable and consistent return through direct and indirect investment mainly in United Kingdom securities.
| Name | % Net Assets | 
|---|---|
| AstraZeneca | 7.5% | 
| KSK Power Ventur | 5.4% | 
| Indus Gas | 5.3% | 
| BP | 4.9% | 
| Resolution | 4.9% | 
| Essar Energy | 4.9% | 
| Reed Elsevier | 4.7% | 
| DS Smith | 4.2% | 
| iEnergizer Ltd | 3.7% | 
| Berkeley Group | 3.6% | 
| Key | % Net Assets | 
|---|---|
| 7.5% | |
| 5.4% | |
| 5.3% | |
| 4.9% | |
| 76.9% | 
| Date | n/a | 
|---|---|
| Bid | 0.00 | 
| Offer | 0.00 | 
| Currency | n/a | 
| Change | 0.00 | 
| % | n/a | 
| YTD change | 0.00 | 
| YTD % | n/a | 
| Fund Inception | 01/06/1964 | 
|---|---|
| Fund Manager | Peter Cockburn | 
| TER | 0.87 (31-Jan-2014) | 
| Minimum Investment | |
|---|---|
| Initial | 1000 | 
| Additional | n/a | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | n/a | 
| Annual Mang't | 0.75% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.02 | 
| Sharpe ratio | 0.07 | 
You are here: research